Overview

A Study to Test the Efficacy and Safety of Padsevonil as Treatment of Focal-onset Seizures in Adult Subjects With Drug-resistant Epilepsy

Status:
Terminated
Trial end date:
2020-09-28
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the efficacy, safety and tolerability of the 3 selected dose regimens of padsevonil (PSL) administered concomitantly with up to 3 anti-epileptic drugs (AEDs) compared with placebo for treatment of observable focal-onset seizures in subjects with drug-resistant epilepsy.
Phase:
Phase 3
Details
Lead Sponsor:
UCB Biopharma S.P.R.L.
UCB Biopharma SRL